Colin B Josephson1, Jordan D T Engbers1,2, Tolulope T Sajobi1,2,3,4, Nathalie Jette1,3,4, Yahya Agha-Khani1, Paolo Federico1,4, William Murphy1, Neelan Pillay1, Samuel Wiebe1,2,3,4. 1. Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. 2. Clinical Research Unit, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. 3. Department of Community Health Sciences and O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. 4. Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
Abstract
OBJECTIVE: Elderly onset epilepsy represents a distinct subpopulation that has received considerable attention due to the unique features of the disease in this age group. Research into this particular patient group has been limited by a lack of a standardized definition and understanding of the attributes associated with elderly onset epilepsy. METHODS: We used a prospective cohort database to examine differences in patients stratified according to age of onset. Linear support vector machine learning incorporating all significant variables was used to predict age of onset according to prespecified thresholds. Sensitivity and specificity were calculated and plotted in receiver-operating characteristic (ROC) space. Feature coefficients achieving an absolute value of 0.25 or greater were graphed by age of onset to define how they vary with time. RESULTS: We identified 2,449 patients, of whom 149 (6%) had an age of seizure onset of 65 or older. Fourteen clinical variables had an absolute predictive value of at least 0.25 at some point over the age of epilepsy-onset spectrum. Area under the curve in ROC space was maximized between ages of onset of 65 and 70. Features identified through machine learning were frequently threshold specific and were similar, but not identical, to those revealed through simple univariable and multivariable comparisons. SIGNIFICANCE: This study provides an empirical, clinically informed definition of "elderly onset epilepsy." If validated, an age threshold of 65-70 years can be used for future studies of elderly onset epilepsy and permits targeted interventions according to the patient's age of onset. Wiley Periodicals, Inc.
OBJECTIVE: Elderly onset epilepsy represents a distinct subpopulation that has received considerable attention due to the unique features of the disease in this age group. Research into this particular patient group has been limited by a lack of a standardized definition and understanding of the attributes associated with elderly onset epilepsy. METHODS: We used a prospective cohort database to examine differences in patients stratified according to age of onset. Linear support vector machine learning incorporating all significant variables was used to predict age of onset according to prespecified thresholds. Sensitivity and specificity were calculated and plotted in receiver-operating characteristic (ROC) space. Feature coefficients achieving an absolute value of 0.25 or greater were graphed by age of onset to define how they vary with time. RESULTS: We identified 2,449 patients, of whom 149 (6%) had an age of seizure onset of 65 or older. Fourteen clinical variables had an absolute predictive value of at least 0.25 at some point over the age of epilepsy-onset spectrum. Area under the curve in ROC space was maximized between ages of onset of 65 and 70. Features identified through machine learning were frequently threshold specific and were similar, but not identical, to those revealed through simple univariable and multivariable comparisons. SIGNIFICANCE: This study provides an empirical, clinically informed definition of "elderly onset epilepsy." If validated, an age threshold of 65-70 years can be used for future studies of elderly onset epilepsy and permits targeted interventions according to the patient's age of onset. Wiley Periodicals, Inc.
Authors: Andrea L C Schneider; Rebecca F Gottesman; Gregory L Krauss; James Gugger; Ramon Diaz-Arrastia; Anna Kucharska-Newton; Juebin Huang; Emily L Johnson Journal: Neurology Date: 2021-12-17 Impact factor: 11.800
Authors: Emily L Johnson; Gregory L Krauss; Alexandra K Lee; Andrea L C Schneider; Jennifer L Dearborn; Anna M Kucharska-Newton; Juebin Huang; Alvaro Alonso; Rebecca F Gottesman Journal: JAMA Neurol Date: 2018-11-01 Impact factor: 18.302
Authors: Phil B Fontanarosa; Annette Flanagin; John Z Ayanian; Robert O Bonow; Neil M Bressler; Dimitri Christakis; Mary L Disis; S Andrew Josephson; Melina R Kibbe; Dost Öngür; Jay F Piccirillo; Rita F Redberg; Frederick P Rivara; Kanade Shinkai; Clyde W Yancy Journal: JAMA Neurol Date: 2021-08-01 Impact factor: 29.907
Authors: Erik Kaestner; Anny Reyes; Austin Chen; Jun Rao; Anna Christina Macari; Joon Yul Choi; Deqiang Qiu; Kelsey Hewitt; Zhong Irene Wang; Daniel L Drane; Bruce Hermann; Robyn M Busch; Vineet Punia; Carrie R McDonald Journal: Brain Date: 2021-02-12 Impact factor: 15.255
Authors: Emily L Johnson; Gregory L Krauss; Anna Kucharska-Newton; Alice D Lam; Rani Sarkis; Rebecca F Gottesman Journal: Neurology Date: 2021-07-19 Impact factor: 11.800